News
Treating COVID-19 in patients with diabetes
Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.
News
Osilodrostat gets FDA go-ahead for Cushing’s disease in adults
The oral cortisol synthesis inhibitor is the first therapy approved by the agency to address the overproduction of cortisol.
News
FDA okays triple-combo pill for type 2 diabetes
The once-daily therapy comprises the well-established medications empagliflozin, linagliptin, and metformin.
News
Teprotumumab gets FDA go-ahead for thyroid eye disease
It is the first drug to be approved for treatment of the debilitating, autoimmune condition.
News
Dapagliflozin approved for reducing HF hospitalization in diabetes
It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.
News
FDA declines dapagliflozin indication as adjunct for type 1 diabetes
AstraZeneca says it has received a complete response letter, but gives no reason for the agency’s decision.
Video
AACE 2019: Top takeaways from Yehuda Handelsman and Paul Jellinger
LOS ANGELES – Yehuda Handelsman, MD, and Paul S. Jellinger, MD, summarized some of the key takeaways from this year’...
